Find your next paid study

VHL Pancreatic Neuroendocrine TumorsVon Hippel-Lindau DiseaseNeuroendocrine Tumors

~$150 – $4,500

Actual pay is set by the research site.

Darell BignerNCT05734560

Phase 2

Evaluation of the Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Background: People with von Hippel-Lindau (VHL) can have problems with a variety of organs, such as the pancreas. The disease can cause tumors of the pancreas…

National Cancer Institute (NCI)NCT04074135

~$75 – $1,800

Actual pay is set by the research site.

Emergency Department VisitHome Care ServicesDementia

Skipping the Hospital: Acute Hospital Care at Home for People Living With Dementia

The investigators will perform a parallel-group multicenter randomized controlled trial of a 1-year pre-enrolled acute hospital care at home intervention vs us…

Brigham and Women's HospitalNCT06819852

Actual pay is set by the research site.

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria

The purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies. Researchers will use mHealth devices to create a sust…

Breast CancerBreast Cancer Female

Memorial Sloan Kettering Cancer CenterNCT05561842

Actual pay is set by the research site.

Phase 2

Safety, Efficacy, and Tumor Immune Microenvironment Changes With Neoadjuvant Chemotherapy and Cemiplimab With or Without Alirocumab in Stage 1B-3A Non-Small Cell Lung Cancer: TOP 2301

This study was originally opened on 10/22/2024 as an open-label, two-arm, randomized phase 2 clinical trial, patients with clinical stage 1B-3A non-small cell …

Non Small Cell Lung Cancer

Duke UniversityNCT06385262

~$75 – $2,000

Actual pay is set by the research site.

Evaluation of DNA Methylation Signatures in Diagnosis and Management of Thyroid Nodules

This clinical trial evaluates deoxyribonucleic acid (DNA) methylation signatures in diagnosing and managing thyroid nodules. The purpose of this research is to…

Thyroid Gland Carcinoma

City of Hope Medical CenterNCT05229341

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of KarXT in male and female subjects …

Psychosis Associated With Alzheimer's Disease

Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT06126224

~$50 – $2,100

Actual pay is set by the research site.

Phase 3

A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator's Choice Therapy in Participants With Relapsed Small Cell Lung Cancer

The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell …

Small-cell Lung Cancer

Zai Lab (Shanghai) Co., Ltd.NCT07218146

~$50 – $2,100

Actual pay is set by the research site.

Phase 3

A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiat…

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

National Cancer Institute (NCI)NCT05675410

~$50 – $1,350

Actual pay is set by the research site.

Renal Cell Carcinoma (RCC)

Development and Analysis of Weight Loss Programs for Renal Cell Carcinoma Patients on Active Surveillance

This clinical trial compares two different weight-loss programs, daily continuous calorie energy reduction (CER) versus (vs.) 5:2 intermittent fasting (IF), in…

Roswell Park Cancer InstituteNCT07714018

~$10 – $1,125

Actual pay is set by the research site.

Phase 2

A Phase 2 Open-Label Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Pembrolizumab as First-Line Treatment in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with an annual incidence of approximately 700,000 cases. This study a…

Head and Neck Squamous Cell Carcinoma

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT07744126

Feasibility of MBSR-VR to Reduce Stress Among Emerging Adults With T1D

The goal of this study is to learn if Mindfulness-Based Stress Reduction (MBSR) can be delivered using virtual reality (VR) technology to emerging adults (yout…

Type 1 Diabetes